For citations:

Kurochkina O.N., Korotkov D.A., Sazhina A.S., Bogomolov A.N. Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect. Rational Pharmacotherapy in Cardiology. 2024;20(2):258-264. (In Russ.) https://doi.org/10.20996/1819-6446-2024-3014. EDN: UZLJIY